{"id":388389,"date":"2020-11-25T07:33:20","date_gmt":"2020-11-25T12:33:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=388389"},"modified":"2020-11-25T07:33:20","modified_gmt":"2020-11-25T12:33:20","slug":"acerus-announces-completion-of-over-subscribed-rights-offering","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/","title":{"rendered":"Acerus Announces Completion of Over-Subscribed Rights Offering"},"content":{"rendered":"

<\/p>\n

Acerus Announces Completion of Over-Subscribed Rights Offering<\/b><\/p>\n

TORONTO–(BUSINESS WIRE<\/a>)–Acerus Pharmaceuticals Corporation<\/b> (\u201cAcerus<\/b>\u201d or the \u201cCompany<\/b>\u201d) (TSX: ASP, OTCQB: ASPCF) is pleased to announce the completion of its rights offering (the \u201cRights Offering<\/b>\u201d), which expired at 5:00 pm (EST) on November 24, 2020. The Rights Offering was over-subscribed and will result in the issuance of 526,600,000 common shares of Acerus at a price of $0.025 per share for gross proceeds of approximately $13,165,000. Although Acerus had a standby commitment in place with First Generation Capital Inc., no funding was required under the standby commitment.\n<\/p>\n

\nAcerus is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and additional subscription privilege, in connection with the Rights Offering and will provide further details, including information required by National Instrument 45-106 \u2013 Prospectus Exemptions<\/i>, once available.\n<\/p>\n

About Acerus <\/b><\/p>\n

\nAcerus Pharmaceuticals Corporation is a Canadian\u2010based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men\u2019s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.\n<\/p>\n

\nAcerus\u2019 Common Shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com<\/a> and follow us on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

Notice Regarding Forward-Looking Statements<\/b><\/p>\n

\nThe TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein.\n<\/p>\n

\nThis news release contains certain “forward-looking statements” and “forward-looking information”. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward- looking statements or forward-looking information can be identified by words such as \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cgoal,\u201d \u201cproject,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cbelieve\u201d, \u201cfuture,\u201d \u201clikely,\u201d \u201cmay,\u201d \u201cshould,\u201d \u201ccould\u201d, \u201cwill\u201d and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding the provision of further details regarding the Rights Offering contained in this news release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important risks, assumptions and factors that could cause actual results to differ materially from Acerus\u2019 plans and expectations include the actual results of business negotiations; the Company\u2019s ability to repay its debts and meet its financial covenants; adverse general economic, market or business conditions including those caused by the Covid-19 pandemic; regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Acerus with securities regulators and stock exchanges, including in the section entitled \u201cRisk Factors\u201d in Acerus\u2019 annual information form dated March 3, 2020 which is available at www.sedar.com<\/a>. Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Acerus disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Acerus believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201125005394\/en\/<\/a><\/span><\/p>\n

\nRobert Motz
\n
Chief Financial Officer
\n
(905) 817-8288
\n
rmotz@aceruspharma.com<\/a>.\n<\/p>\n

KEYWORDS:<\/b> North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Acerus Announces Completion of Over-Subscribed Rights Offering TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (\u201cAcerus\u201d or the \u201cCompany\u201d) (TSX: ASP, OTCQB: ASPCF) is pleased to announce the completion of its rights offering (the \u201cRights Offering\u201d), which expired at 5:00 pm (EST) on November 24, 2020. The Rights Offering was over-subscribed and will result in the issuance of 526,600,000 common shares of Acerus at a price of $0.025 per share for gross proceeds of approximately $13,165,000. Although Acerus had a standby commitment in place with First Generation Capital Inc., no funding was required under the standby commitment. Acerus is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and additional subscription privilege, in connection with the Rights Offering … <\/p>\n

Continue reading “Acerus Announces Completion of Over-Subscribed Rights Offering”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-388389","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAcerus Announces Completion of Over-Subscribed Rights Offering - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acerus Announces Completion of Over-Subscribed Rights Offering - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Acerus Announces Completion of Over-Subscribed Rights Offering TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (\u201cAcerus\u201d or the \u201cCompany\u201d) (TSX: ASP, OTCQB: ASPCF) is pleased to announce the completion of its rights offering (the \u201cRights Offering\u201d), which expired at 5:00 pm (EST) on November 24, 2020. The Rights Offering was over-subscribed and will result in the issuance of 526,600,000 common shares of Acerus at a price of $0.025 per share for gross proceeds of approximately $13,165,000. Although Acerus had a standby commitment in place with First Generation Capital Inc., no funding was required under the standby commitment. Acerus is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and additional subscription privilege, in connection with the Rights Offering … Continue reading "Acerus Announces Completion of Over-Subscribed Rights Offering"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-25T12:33:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Acerus Announces Completion of Over-Subscribed Rights Offering\",\"datePublished\":\"2020-11-25T12:33:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/\"},\"wordCount\":609,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/\",\"name\":\"Acerus Announces Completion of Over-Subscribed Rights Offering - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-11-25T12:33:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acerus-announces-completion-of-over-subscribed-rights-offering\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acerus Announces Completion of Over-Subscribed Rights Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acerus Announces Completion of Over-Subscribed Rights Offering - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/","og_locale":"en_US","og_type":"article","og_title":"Acerus Announces Completion of Over-Subscribed Rights Offering - Market Newsdesk","og_description":"Acerus Announces Completion of Over-Subscribed Rights Offering TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (\u201cAcerus\u201d or the \u201cCompany\u201d) (TSX: ASP, OTCQB: ASPCF) is pleased to announce the completion of its rights offering (the \u201cRights Offering\u201d), which expired at 5:00 pm (EST) on November 24, 2020. The Rights Offering was over-subscribed and will result in the issuance of 526,600,000 common shares of Acerus at a price of $0.025 per share for gross proceeds of approximately $13,165,000. Although Acerus had a standby commitment in place with First Generation Capital Inc., no funding was required under the standby commitment. Acerus is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and additional subscription privilege, in connection with the Rights Offering … Continue reading \"Acerus Announces Completion of Over-Subscribed Rights Offering\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-25T12:33:20+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Acerus Announces Completion of Over-Subscribed Rights Offering","datePublished":"2020-11-25T12:33:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/"},"wordCount":609,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/","name":"Acerus Announces Completion of Over-Subscribed Rights Offering - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-11-25T12:33:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201125005394r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acerus-announces-completion-of-over-subscribed-rights-offering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Acerus Announces Completion of Over-Subscribed Rights Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=388389"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388389\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=388389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=388389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=388389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}